Leap Therapeutics, Inc.
LPTX
$0.4152
-$0.0029-0.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.67% | -32.71% | -50.32% | 66.99% | -3.00% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -4.17% | 0.96% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 356.56% | -23.78% | -5.78% | -95.94% | -51.11% |
| Change in Net Operating Assets | -205.90% | -13.54% | 204.51% | -46.65% | 193.74% |
| Cash from Operations | -49.44% | -48.74% | -34.23% | -22.17% | 20.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -6,500.00% | -- | 200.00% | -- |
| Foreign Exchange rate Adjustments | -159.29% | 105.46% | 224.44% | -370.00% | 35.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.20% | -46.70% | 321.76% | -143.03% | 21.14% |